20^th European Gastroenterology and Therapeutics Congress

Liver Cirrhosis and Complications

Liver cirrhosis, the advanced stage of chronic liver disease, is a major contributor to global morbidity and mortality. This session focuses on the pathogenesis, complications, and management of cirrhosis arising from various causes such as alcohol-related liver disease, chronic hepatitis B and C, and non-alcoholic steatohepatitis (NASH). Key complications—including portal hypertension, hepatic encephalopathy, variceal bleeding, ascites, and hepatocellular carcinoma—will be discussed with an emphasis on early recognition and intervention. The session highlights advancements in non-invasive diagnostic tools like transient elastography (FibroScan), serum fibrosis markers, and imaging techniques to assess liver fibrosis and function. Therapeutic strategies such as transjugular intrahepatic portosystemic shunt (TIPS), endoscopic band ligation, and targeted pharmacologic therapies will be explored. Multidisciplinary care models, nutritional support, and transplant evaluation protocols are vital in managing decompensated cirrhosis. By focusing on both prevention and comprehensive management, this session aims to improve patient outcomes and quality of life.